Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse

Endocrinology

Volumn 153, Issue 8, 2012, Pages 3886-3896

  Waeckel, Ludovic ^a,b,c   Potier, Louis ^a,b,c   Chollet, Catherine ^a,b,c   Taveau, Christopher ^a,b,c   Bruneval, Patrick ^b,d   Roussel, Ronan ^a,b,c,e   Alhenc Gelas, François ^a,b,c   Bouby, Nadine ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; MESSENGER RNA; SODIUM CHLORIDE; TISSUE KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CARDIAC SEPTAL HYPERTROPHY; CONTROLLED STUDY; DISEASE EXACERBATION; GENOTYPE; HEART VENTRICLE HYPERTROPHY; HYPERALDOSTERONISM; KIDNEY MASS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RENIN RELEASE; SODIUM RETENTION; TELEMETRY; WILD TYPE;

ALDOSTERONE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HYPERALDOSTERONISM; MALE; MICE; RENIN; SODIUM CHLORIDE; SODIUM CHLORIDE, DIETARY; TISSUE KALLIKREINS;

EID: 84864390261     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1225     Document Type: Article

References (59)

1. Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW 2008 Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19:88-90 (Pubitemid 351442920)
2. Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E 2008 A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29:133-154 (Pubitemid 351519688)
3. Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M 2010 Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res 42:374-381
4. Fuller PJ, Young MJ 2005 Mechanisms of mineralocorticoid action. Hypertension 46:1227-1235 (Pubitemid 43189712)
5. Yoshimoto T, Hirata Y 2007 Aldosterone as a cardiovascular risk hormone. Endocr J 54:359-370 (Pubitemid 47105422)
6. Carretero O, Scicli A 1995 The kallikrein-kinin system as a regulator of cardiovascular and renal function. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management New York: Raven Press; 983-999
7. Meneton P, Bloch-Faure M, Hagege AA, Ruetten H, Huang W, Bergaya S, Ceiler D, Gehring D, Martins I, Salmon G, Boulanger CM, Nussberger J, Crozatier B, Gasc JM, Heudes D, Bruneval P, Doetschman T, Ménard J, Alhenc-Gelas F 2001 Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci USA 98:2634-2639 (Pubitemid 32209534)
8. Bergaya S, Hilgers RH, Meneton P, Dong Y, Bloch-Faure M, Inagami T, Alhenc-Gelas F, Lévy BI, Boulanger CM 2004 Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res 94:1623-1629 (Pubitemid 38856970)
9. Azizi M, Boutouyrie P, Bissery A, Agharazii M, Verbeke F, Stern N, Bura-Rivière A, Laurent S, Alhenc-Gelas F, Jeunemaitre X 2005 Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest 115:780-787 (Pubitemid 40322255)
10. Tomita K, Pisano JJ, Knepper MA 1985 Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest 76:132-136 (Pubitemid 15240427)
11. Grider J, Falcone J, Kilpatrick E, Ott C, Jackson B 1995 Effect of bradykinin on NaCl transport in the medullary thick ascending limb of the rat. Eur J Pharmacol 287:101-104
12. Saitoh S, Scicli AG, Peterson E, Carretero OA 1995 Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion. Hypertension 25:1008-1013
13. Picard N, Van Abel M, Campone C, Seiler M, Bloch-Faure M, Hoenderop JG, Loffing J, Meneton P, Bindels RJ, Paillard M, Alhenc-Gelas F, Houillier P 2005 Tissue kallikrein-deficient mice display a defect in renal tubular calcium absorption. J Am Soc Nephrol 16:3602-3610 (Pubitemid 46211281)
14. Blanchard A, Azizi M, Peyrard S, Stern N, Alhenc-Gelas F, Houillier P, Jeunemaitre X 2007 Partial human genetic deficiency in tissue kallikrein activity and renal calcium handling. Clin J Am Soc Nephrol 2:320-325
15. Picard N, Eladari D, El Moghrabi S, Planès C, Bourgeois S, Houillier P, Wang Q, Burnier M, Deschenes G, Knepper MA, Meneton P, Chambrey R 2008 Defective ENaC processing and function in tissue kallikrein-deficient mice. J Biol Chem 283:4602-4611
16. Margolius HS, Geller RG, De Jong W, Pisano JJ, Sjoerdsma A 1972 Urinary kallikrein excretion in hypertension. Circ Res 31(Suppl 2):125-131
17. Lechi A, Covi G, Lechi C, Corgnati A, Arosio E, Zatti M, Scuro LA 1978 Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism. Clin Sci Mol Med 55:51-55 (Pubitemid 8382444)
18. Hesse B, Rasmussen S, Lund JO, Christensen P, Damkjaer Nielsen M 1985 Urinary excretion of kallikrein before and after operation for aldosterone-producing adenoma. Acta Med Scand 217:501-505 (Pubitemid 15019668)
19. Hayami S, Nakada T, Kakizaki H, Yagisawa T, Kaneko H, Iijima Y, Obata H, Miura M 1994 Changes in urinary kallikrein excretion and plasma natriuretic factor in a patient with primary aldosteronism with special reference to adrenal histology. Int Urol Nephrol 26:375-381 (Pubitemid 24293989)
20. Ura N, Shimamoto K, Nomura N, Iwata M, Aoyama T, Takagawa Y, Iimura O 1995 Significance of renal kininases in patients with primary aldosteronism. Clin Exp Hypertens 17:1049-1058
21. Seino M, Abe K, Sakurai Y, Irokawa N, Yasujima M, Chiba S, Otsuka Y, Yoshinaga K 1977 Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism. Tohoku J Exp Med 121:111-119 (Pubitemid 8050908)
22. Margolius HS, Horwitz D, Geller RG, Alexander RW, Gill Jr JR, Pisano JJ, Keiser HR 1974 Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids. Circ Res 35:812-819
23. Levy SB, Frigon RP, Stone RA 1978 The relationship of urinary kallikrein activity to renal salt and water excretion. Clin Sci Mol Med 54:39-45 (Pubitemid 8288462)
24. Lieberthal W, Oza NB, Arbeit L, Bernard DB, Levinsky NG 1983 Effects of alterations in sodium and water metabolism on urinary excretion of active and inactive kallikrein in man. J Clin Endocrinol Metab 56:513-519 (Pubitemid 13157796)
25. Fejes-Tóth G, Náray-Fejes-Tóth A 1984 Effect of aldosterone on urinary kallikrein and prostaglandin excretion in the rat. J Physiol 354:79-88 (Pubitemid 14066354)
26. Bascands JL, Girolami JP, Pecher C, Moatti JP, Manuel Y, Suc JM 1987 Compared effects of a low and a high sodium diet on the renal and urinary concentration and activity of kallikrein in normal rats. J Hypertens 5:311-315
27. Gilboa N, Rudofsky UH, Phillips MI, Magro AM 1989 Modulation of urinary kallikrein and plasma renin activities does not affect established hypertension in the fawn-hooded rat. Nephron 51:61-66 (Pubitemid 19001761)
28. Azizi M, Emanueli C, Peyrard S, Maddedu P, Alhenc-Gelas F, Campbell DJ 2008 Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man. J Hypertens 26:714-720 (Pubitemid 351354919)
29. Wang Q, Hummler E, Nussberger J, Clément S, Gabbiani G, Brunner HR, Burnier M 2002 Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of renin genes. J Am Soc Nephrol 13:1509-1516 (Pubitemid 34579240)
30. Trabold F, Pons S, Hagege AA, Bloch-Faure M, Alhenc-Gelas F, Giudicelli JF, Richer-Giudicelli C, Meneton P 2002 Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice. Hypertension 40:90-95 (Pubitemid 34755985)
31. Lum C, Shesely EG, Potter DL, Beierwaltes WH 2004 Cardiovascular and renal phenotype in mice with one or two renin genes. Hypertension 43:79-86 (Pubitemid 38031914)
32. Butz GM, Davisson RL 2001 Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 5:89-97 (Pubitemid 33675206)
33. Griol-Charhbili V, Sabbah L, Colucci J, Vincent MP, Baudrie V, Laude D, Elghozi JL, Bruneval P, Picard N, Meneton P, Alhenc-Gelas F, Richer C 2009 Tissue kallikrein deficiency and renovascular hypertension in the mouse. Am J Physiol Regul Integr Comp Physiol 296:R1385-R1391
34. Menard J, Catt KJ 1972 Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 90:422-430
35. Bodin S, Chollet C, Goncalves-Mendes N, Gardes J, Pean F, Heudes D, Bruneval P, Marre M, Alhenc-Gelas F, Bouby N 2009 Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int 76:395-403
36. Schmittgen TD, Livak KJ 2008 Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108 (Pubitemid 351818697)
37. Alfie ME, Sigmon DH, Pomposiello SI, Carretero OA 1997 Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension 29:483-487 (Pubitemid 27074087)
38. Rhaleb NE, Peng H, Alfie ME, Shesely EG, Carretero OA 1999 Effect of ACE inhibitor on DOCA-salt- and aortic coarctation-induced hypertension in mice: do kinin B2 receptors play a role? Hypertension 33:329-334 (Pubitemid 29065680)
39. Sontia B, Montezano AC, Paravicini T, Tabet F, Touyz RM 2008 Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertension 51:915-921 (Pubitemid 351654704)
40. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, Haystead TA, Donoghue M, Breitbart RE, Acton SL, Rockman HA, Coffman TM2006 Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 116:2218-2225 (Pubitemid 44162331)
41. Hettinger U, Lukasova M, Lewicka S, Hilgenfeldt U 2002 Regulatory effects of salt diet on renal renin-angiotensin-aldosterone, and kallikrein-kinin systems. Int Immunopharmacol 2:1975-1980 (Pubitemid 35373937)
42. Marchetti J, Imbert-Teboul M, Alhenc-Gelas F, Allegrini J, Menard J, Morel F 1984 Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA treatment. Pflugers Arch 401:27-33 (Pubitemid 14117980)
43. Zaika O, Mamenko M, O'Neil RG, Pochynyuk O 2011 Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron. Am J Physiol Renal Physiol 300:F1105-F1115
44. Nolly H, Nolly A 1998 Release of endothelial-derived kallikrein, kininogen and kinins. Biol Res 31:169-174 (Pubitemid 28468267)
45. Wolf WC, Harley RA, Sluce D, Chao L, Chao J 1999 Localization and expression of tissue kallikrein and kallistatin in human blood vessels. J Histochem Cytochem 47:221-228 (Pubitemid 29053064)
46. Bergaya S, Meneton P, Bloch-Faure M, Mathieu E, Alhenc-Gelas F, Lévy BI, Boulanger CM 2001 Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ Res 88:593-599 (Pubitemid 32275795)
47. Hilgers RH, Bergaya S, Schiffers PM, Meneton P, Boulanger CM, Henrion D, Lévy BI, De Mey JG 2003 Uterine artery structural and functional changes during pregnancy in tissue kallikrein-deficient mice. Arterioscler Thromb Vasc Biol 23:1826-1832 (Pubitemid 37254870)
48. Pinto YM, Paul M, Ganten D 1998 Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 39:77-88 (Pubitemid 28322381)
49. Sam F, Xie Z, Ooi H, Kerstetter DL, Colucci WS, Singh M, Singh K 2004 Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am J Hypertens 17:188-193 (Pubitemid 38125138)
50. Karatas A, Hegner B, de Windt LJ, Luft FC, Schubert C, Gross V, Akashi YJ, Gürgen D, Kintscher U, da Costa Goncalves AC, Regitz-Zagrosek V, Dragun D 2008 Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism. Hypertension 51:1177-1183 (Pubitemid 351398989)
51. López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J 2011 A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. Am J Physiol Heart Circ Physiol 301:H2372-H2382
52. Rickard AJ, Funder JW, Morgan J, Fuller PJ, Young MJ 2007 Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration? Endocrinology 148:4829-4835 (Pubitemid 47481545)
53. Le Menuet D, Isnard R, Bichara M, Viengchareun S, Muffat-Joly M, Walker F, Zennaro MC, Lombès M 2001 Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor. J Biol Chem 276:38911-38920
54. Ouvrard-Pascaud A, Sainte-Marie Y, Bénitah JP, Perrier R, Soukaseum C, Nguyen Dinh Cat A, Royer A, Le Quang K, Charpentier F, Demolombe S, Mechta-Grigoriou F, Beggah AT, Maison-Blanche P, Oblin ME, Delcayre C, Fishman GI, Farman N, Escoubet B, Jaisser F 2005 Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation 111:3025-3033 (Pubitemid 40847778)
55. Wang Q, Clement S, Gabbiani G, Horisberger JD, Burnier M, Rossier BC, Hummler E 2004 Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet. Am J Physiol Renal Physiol 286:F1178-F1184 (Pubitemid 38656375)
56. Jaisser F, Swynghedauw B, Delcayre C 2011 The mineralocorticoid receptor in heart: different effects in different cells. Hypertension 57:679-680
57. Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF 2009 Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 53:605-610
58. Slim R, Torremocha F, Moreau T, Pizard A, Hunt SC, Vuagnat A, Williams GH, Gauthier F, Jeunemaitre X, Alhenc-Gelas F 2002 Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity. J Am Soc Nephrol 13:968-976 (Pubitemid 34274093)
59. Mulatero P, Williams TA, Milan A, Paglieri C, Rabbia F, Fallo F, Veglio F 2002 Blood pressure in patients with primary aldosteronism is influenced by bradykinin B(2) receptor and α-adducin gene polymorphisms. J Clin Endocrinol Metab 87:3337-3343 (Pubitemid 34816386)